Elad Software Systems stock has been marking time, with the latest close at ₪10.07 after a mixed few months, yet the fresh Q2 print tells a tighter story. The market is treating Elad like just another mid cap IT contractor. The headline is that profitability quietly did the heavy lifting. Net income from ongoing operations reached ₪8.1m in Q2 and trailing 12 month net profit margin held at 5.4% with a trailing P/E of 17.4x. For a stock trading below some analyst fair value estimates, that margin resilience is the real tension in this quarter.
Love Elad Software Systems' steady 5.4% net margin but unsure if its 17.4x P/E is really compelling value? Benchmark it against our 270 high quality undervalued stocks to see how it compares on quality and pricing.
Prefer clear visuals to scrolling through dense tables and raw figures? View Elad Software Systems' complete financial picture with an at-a-glance summary of its valuation in the company report for Elad Software Systems.
For investors leaning positive on Elad Software Systems as a defensive IT and healthcare software partner, the latest quarter broadly fits that script. Revenue in Q2 2026 moved higher compared with Q2 2025 and net income stayed slightly ahead, which keeps the trailing net margin at 5.4%. That small margin improvement versus the prior year supports a view of operational discipline. Earnings per share also inched up. Together, these trends back a thesis that Elad’s mix of services and healthcare IT can produce relatively consistent profitability through ordinary trading conditions.
More cautious investors will notice that while Elad Software Systems is profitable, earnings momentum looks modest. Net income from ongoing operations rose only slightly versus Q2 2025 and basic EPS was broadly unchanged. That can reinforce concerns about limited near term operating leverage, especially for those looking for sharper profit expansion from digital transformation or healthcare IT exposure. Recent share price performance also shows some weakness over 30 and 90 days. For now, the numbers point to resilience rather than clear acceleration, which may leave growth focused investors unconvinced.
With earnings growth slowing from the 30.7% five year pace to 11% most recently, the key question is whether Elad Software Systems has the balance sheet strength to support future investment. Verify that with the full financial health analysis of Elad Software Systems stock.If Elad Software Systems' steady 5.4% net margin and 17.4x P/E have caught your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for your preferred entry point. After you own the stock, keep your decisions clear by using the Portfolio Command Center to filter out noise and surface only the updates that matter most to your holdings. Round out your thinking with the Community where you can see how other investors are interpreting the same data and key developments. By catching potential catalysts and risks early, you may give yourself a better chance to stay ahead of the market.
Some stocks start breaking out quietly while attention stays elsewhere. Use these fresh idea lists before momentum is fully caught, while the data still matters. Get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com